A Combination of Plerixafor and Filgrasting Promotes Successful CD34+ Cell Collection for CRISPR/Cas9 Therapy in Sickle Cell Disease Patients With Insufficient Response to Plerixafor Alone.

Francesco Arcioni, Marta Bonetti, Antonella Sau, Marco Zecca, Mohsen Alzahrani, Bader Alahmari, Husam Alsadi, Ayman Almozaini, Mazen Ahmed, Mohammed Essa, Cesare Perotti, Claudia Del Fante, Cecilia Passeri, Ornella Iuliani, Anna C Russo